Gary Sterba
Rheumatology · Miami, FLNPI 1942504832
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by ANI Pharmaceuticals, Inc. at 25.7% of the total. That places this record below the midpoint for rheumatology clinicians in FL, where the typical reported total is $6,335.
Across 66 payments — averaging $40.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ANI Pharmaceuticals, Inc.$689
- Astrazeneca UK Limited$396
- Mallinckrodt Hospital Products Inc.$264
- Aurinia Pharma U.S., Inc.$244
- AbbVie$243
- AstraZeneca$217
- plus $629 from 8 others
Across 18 payments — averaging $48,896 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$728K
- Astrazeneca UK Limited$152K
What the payments were for
- Travel & lodging$1305%
- Food & beverage$2,54595%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 21 | $689 |
| Astrazeneca UK Limited | 5 | $396 |
| Mallinckrodt Hospital Products Inc. | 11 | $264 |
| Aurinia Pharma U.S., Inc. | 2 | $244 |
| AbbVie | 7 | $243 |
| AstraZeneca | 2 | $217 |
| Lilly USA, LLC | 5 | $158 |
| Sanofi | 1 | $148 |
| GSK | 3 | $147 |
| Boehringer Ingelheim | 3 | $77 |
| Amgen | 3 | $51 |
| Radius Health, Inc. | 1 | $17 |
| Gilead | 1 | $17 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURIFIED CORTROPHIN GEL$286
- LUPKYNIS$244
- SAPHNELO$126
- BENLYSTA$115
How this compares
$2,682 in reported general payments places this provider in the 35th percentile of 453 rheumatology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olmesartan Medoxomil | 12 | $203 |
| Prednisone | 15 | $85 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Miami
- Michael WeitzMiami$658K
- Joseph la ContiMiami$345K
- Robert HoffmanMiami$241K
- Christopher MesaMiami$198K
- George MunozMiami$147K
- Santiago de SoloMiami$98K
- Carlos LozadaMiami$97K
- Reuven BrombergMiami$78K
- Jeffrey RitterMiami$39K
- Alvin WellsDestin$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.